A Georgia man has sued a pharmaceutical company for manufacturing and selling type 2 diabetes-control drug Pioglitazon, which allegedly caused him great injury and suffering.
Harold Lenz, of Georgia, filed a lawsuit April 1 in St. Clair County Circuit Court against Takeda Pharmaceuticals U.S.A. (formerly known as Takeda Pharmaceuticals North America Inc. or Takeda Pharmaceuticals America Inc.), Takeda Pharmaceuticals, Takeda Pharmaceuticals International Inc., Takeda Global Research and Development Center Inc., Takeda California Inc. (formerly known as Takeda San Diego Inc.) and Takeda Pharmaceutical Co., citing negligence
According to the suit, Lenz complained of "negative and detrimental effects" to his "bladder and urinary system gradually over time and duration. The lawsuit states, this should prove Pioglitazon was "defectively designed, inadequately tested, dangerous to human health and lacked proper warnings as to the dangers associated with its use."
Court documents state, Lenz suffered bladder cancer, loss of appetite, weight loss, blood in his urine, back and abdominal pain, frequent urination with pain, bowel difficulties and other severe and personal injuries that he considers permanent.
Lenz seeks in excess of $50,000, plus costs. He is represented by attorney John J. Driscoll of The Driscoll Firm in St. Louis.
St. Clair County Circuit Court case number 15-L-188
Takeda sued over alleged negligent production of type 2 diabetes drug Pioglitazon
ORGANIZATIONS IN THIS STORY